STOCK TITAN

Intra-Cellular Therapies to Present at the 2021 Cantor Virtual Global Healthcare Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

Intra-Cellular Therapies, Inc. (Nasdaq: ITCI) announced that CEO Sharon Mates, Ph.D., will present at the 2021 Cantor Virtual Global Healthcare Conference on September 28, 2021, at 10:40 am ET. Investors can access the live and archived webcast in the Investor Relations section of the company's website. Intra-Cellular Therapies focuses on developing therapeutics for central nervous system disorders, leveraging groundbreaking research to create innovative treatments for complex psychiatric and neurologic diseases.

Positive
  • None.
Negative
  • None.

NEW YORK, Sept. 22, 2021 (GLOBE NEWSWIRE) -- Intra-Cellular Therapies, Inc. (Nasdaq: ITCI), a biopharmaceutical company focused on the development and commercialization of therapeutics for central nervous system (CNS) disorders, today announced that Sharon Mates, Ph.D., Chief Executive Officer and Chairman, is scheduled to present at the 2021 Cantor Virtual Global Healthcare Conference on Tuesday, September 28, 2021 at 10:40 am ET.

The live and archived webcast can be accessed under "Events & Presentations" in the Investor Relations section of the Company's website at www.intracellulartherapies.com. Please log in approximately 5-10 minutes prior to the event to register and to download and install any necessary software.

About Intra-Cellular Therapies

Intra-Cellular Therapies is a biopharmaceutical company founded on Nobel prize-winning research that allows us to understand how therapies affect the inner-workings of cells in the body. The company leverages this intracellular approach to develop innovative treatments for people living with complex psychiatric and neurologic diseases. For more information, please visit www.intracellulartherapies.com.

Contact:

Intra-Cellular Therapies, Inc.
Juan Sanchez, M.D.
Vice President, Corporate Communications and Investor Relations
646-440-9333

Burns McClellan, Inc.
Lisa Burns
cradinovic@burnsmc.com
212-213-0006


FAQ

When is the 2021 Cantor Virtual Global Healthcare Conference presentation for ITCI?

Sharon Mates, CEO of Intra-Cellular Therapies, will present on September 28, 2021, at 10:40 am ET.

How can I access the ITCI presentation at the healthcare conference?

The presentation can be accessed through the Investor Relations section of Intra-Cellular Therapies' website.

What is the focus of Intra-Cellular Therapies?

Intra-Cellular Therapies develops therapeutics for central nervous system disorders.

Who is presenting for ITCI at the conference?

Sharon Mates, Ph.D., CEO and Chairman, is the presenter.

What time is the ITCI presentation at the conference?

The presentation is scheduled for 10:40 am ET.

Intra-Cellular Therapies Inc.

NASDAQ:ITCI

ITCI Rankings

ITCI Latest News

ITCI Stock Data

8.83B
101.92M
2.33%
96.32%
1.64%
Drug Manufacturers - Specialty & Generic
Pharmaceutical Preparations
Link
United States of America
BEDMINSTER